The JP Jenkins-15 April/May Index update
Thursday, 12 June 2025 03:00 AM
Company Update
The JP Jenkins-15 April/May Index update
Benchmark index records monthly loss of less than 1%
LONDON, UK / ACCESS Newswire / June 12, 2025 / The JP Jenkins (www.jpjenkins.com) proprietary index covering the performance of the venue's 15 largest stocks has been calculated after the close on 6th June 2025. This shows the index trading at 1053.11, down 0.69% from the previous calculation on 2nd May.
Despite steady levels of trade across a number of stocks, only small moves in some constituent share prices were seen during the period.
The index will next be calculated using closing prices from Friday, 4th July.
Veronika Oswald, Commercial Director, JP Jenkins, commented:
"The relative stability of the index belies the fact that we are seeing steady underlying transaction volume, simply with shares changing hands at relatively static prices, as would be expected for the most part from unlisted companies."
In May 2025, JP Jenkins successfully concluded the share-for-share exchange of 5.5 million shares for new member Hornby - totalling over £1 million in value -across 12 leading brokers, including Hargreaves Lansdown, AJ Bell, Interactive Investor and Canaccord.
The index is market cap weighted, with the maximum weighting capped at 20%.
About JP Jenkins
JP Jenkins is the UK's largest venue for unlisted assets. The company provides an efficient platform for privately held and unlisted businesses who are seeking a liquidity solution for holders of their securities. By using market-leading technology from InfinitX, any registered broker or financial institution can now connect, execute and settle with JP Jenkins over existing market infrastructures.
Media contact
Tony Cross
Monk Communications
[email protected]
+44 (0) 7973 284749
-------------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
SOURCE: JP Jenkins Ltd